Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 20 studies | 63% ± 14% | |
| lung | 19 studies | 54% ± 16% | |
| intestine | 13 studies | 37% ± 16% | |
| kidney | 9 studies | 33% ± 17% | |
| pancreas | 5 studies | 50% ± 20% | |
| placenta | 5 studies | 46% ± 19% | |
| bone marrow | 5 studies | 46% ± 24% | |
| uterus | 5 studies | 58% ± 17% | |
| liver | 5 studies | 35% ± 11% | |
| lymph node | 5 studies | 56% ± 14% | |
| prostate | 4 studies | 45% ± 9% | |
| breast | 4 studies | 63% ± 8% | |
| heart | 3 studies | 24% ± 6% | |
| skin | 3 studies | 52% ± 21% | |
| adrenal gland | 3 studies | 38% ± 16% | |
| esophagus | 3 studies | 62% ± 17% | |
| thymus | 3 studies | 54% ± 26% | |
| brain | 3 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 20918.19 | 1445 / 1445 | 100% | 1057.83 | 183 / 183 |
| ovary | 100% | 11266.76 | 180 / 180 | 100% | 851.03 | 429 / 430 |
| lung | 100% | 48555.34 | 578 / 578 | 100% | 1454.22 | 1151 / 1155 |
| stomach | 100% | 18733.02 | 359 / 359 | 100% | 920.57 | 285 / 286 |
| bladder | 100% | 18559.67 | 21 / 21 | 99% | 1495.95 | 500 / 504 |
| uterus | 100% | 16802.74 | 170 / 170 | 99% | 1560.70 | 455 / 459 |
| breast | 100% | 25704.98 | 459 / 459 | 99% | 1220.77 | 1105 / 1118 |
| intestine | 99% | 16849.18 | 960 / 966 | 99% | 1045.39 | 524 / 527 |
| skin | 100% | 27634.29 | 1809 / 1809 | 99% | 915.66 | 466 / 472 |
| thymus | 100% | 15684.82 | 651 / 653 | 95% | 612.93 | 577 / 605 |
| pancreas | 94% | 11476.84 | 309 / 328 | 99% | 1393.04 | 176 / 178 |
| kidney | 100% | 17136.73 | 89 / 89 | 91% | 600.32 | 822 / 901 |
| adrenal gland | 98% | 10199.60 | 253 / 258 | 72% | 369.97 | 166 / 230 |
| liver | 73% | 9016.03 | 166 / 226 | 93% | 613.03 | 378 / 406 |
| prostate | 100% | 15314.57 | 245 / 245 | 62% | 183.97 | 310 / 502 |
| adipose | 100% | 26211.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 1209.36 | 29 / 29 |
| spleen | 100% | 33534.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 1705.14 | 45 / 45 |
| blood vessel | 100% | 20421.66 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 65409.70 | 926 / 929 | 0% | 0 | 0 / 0 |
| heart | 99% | 14604.11 | 850 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 337.80 | 68 / 80 |
| brain | 35% | 2464.07 | 913 / 2642 | 37% | 264.10 | 262 / 705 |
| muscle | 27% | 1591.79 | 217 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007015 | Biological process | actin filament organization |
| GO_0030855 | Biological process | epithelial cell differentiation |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031982 | Cellular component | vesicle |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TAGLN2 |
| Protein name | Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog) Transgelin 2 |
| Synonyms | KIAA0120 CDABP0035 |
| Description | |
| Accessions | X6RJP6 ENST00000320307.8 [P37802-1] ENST00000368097.9 [P37802-1] ENST00000368096.5 [P37802-2] ENST00000397334.2 Q5ZEZ7 P37802 |